| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT00549536 |
| P6099 | clinical trial phase | phase IV clinical trial | Q42825046 |
| P767 | contributor to the creative work or subject | Hellenic Society of Hypertension | Q50036107 |
| P17 | country | Greece | Q41 |
| P582 | end time | 2008-05-01 | |
| P4135 | maximum age | 85 | |
| P1050 | medical condition | arterial hypertension | Q41861 |
| P2899 | minimum age | 18 | |
| P1132 | number of participants | 31 | |
| P4844 | research intervention | calcium oxalate | Q412399 |
| P6153 | research site | Aristotle University of Thessaloniki | Q667568 |
| P580 | start time | 2007-01-01 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | The Effect of Oral Calcium Supplementation on Insulin Sensitivity, Intracellular Cationic Concentrations and the Transmembrane Sodium/Hydrogen Exchanger Activity in Subjects With Type 2 Diabetes and Hypertension |
Search more.